Steven Davidoff Solomon writes for The New York Times, Nov. 14, 2015
Pfizer wants to acquire Allergan not to build a better business by bringing together the makers of Botox and Viagra, but because the move will lower its taxes.
Steven Davidoff Solomon writes for The New York Times, Nov. 14, 2015
Pfizer wants to acquire Allergan not to build a better business by bringing together the makers of Botox and Viagra, but because the move will lower its taxes.